Drug Evaluation Committee Presentation Slides: “Innovative Approaches by Pharmaceutical Manufacturers to Providing Drug Information and Future Prospects for Promoting Its Utilization” (October 18, 2026, 20th Annual Assembly of the Japanese Society of Pharmacy)
November 2026
This document is a lecture slide at the following symposium.
The 20th Annual Assembly of the Japanese Society of Pharmaceutical Sciences (October 18, 2026)
Symposium 10: “Are You Making the Most of It? The Latest Drug Safety Information—Moving from ‘Information You Know’ to ‘Information You Use’: Breaking Through Current Barriers”
Presentation Slides (Symposium 10, 20th Assembly of the Japanese Society of Community Pharmacy)
This presentation introduced the utilization of drug safety information in pharmacies, focusing on Risk Management Plans (RMPs) and RMP materials.
Based on the PMDA’s Reiwa 7 survey results, the presentation highlighted that challenges remain regarding the understanding and utilization of RMPs. Furthermore, it proposed a hypothesis identifying three barriers to utilization—“access,” “awareness,” and “application”—and introduced initiatives by pharmaceutical companies along with practical tips for implementing RMPs in pharmacies.Furthermore, the presentation offered a vision for creating an environment where stakeholders can collaborate so that the necessary information can be “encountered” at the right time and in the right context.
I hope the content of this presentation will serve as a helpful resource for considering the understanding and utilization of drug safety information.
Please note that the content of this presentation reflects the speaker’s personal views and is not intended to endorse any specific company, product, or service.
